Listen

Description

References:

Weight loss on GLP-1 receptor agonists

Moiz A, Levett JY, Filion KB, et al. Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Cardiol 2024, 222:121-130.

Highlights: On average, weight loss on semaglutide (Ozempic) is approximately 15% of body weight.

Gastrointestinal adverse effects of GLP-1 receptor agonists

Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M. Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. JAMA 2023.

Nutrient Density and Satiety:

Anti-Angiogenic Effects of Vegetables and Mushrooms:

Role of Fiber in Appetite Suppression:

Green Tea and Weight Regulation:

Nut Consumption and Caloric Absorption: